Abbey J, Palk E, Carlson L, Parker D. Clinical practice guidelines and care pathways for people with dementia living in the community. 2008. Queensland University of Technology, Brisbane (freely accessible 1.1MB pdf)
The guidelines and pathways encompass non–pharmacological care for the person with dementia from recognition, assessment and diagnosis until death. The guidelines and pathways are intended to be used by health professionals and policy makers who plan, organise and deliver care for people who have dementia and their carers.
Hines S, McCrow J, Abbey J, Foottit J, Wilson J, Franklin S, Beattie E. The effectiveness and appropriateness of a palliative approach to care for people with advanced dementia: a systematic review. JBI Libr Syst Rev. 2011;9(26):960-1131. doi: 10.11124/01938924-201109260-00001.
A systematic review from the Joanna Briggs Institute evidence on effectiveness and appropriateness of a palliative approach to care for people with advanced dementia.
Parker D, Lewis J, Gourlay K, Dementia Australia’s Dementia Advisory Committee. Palliative Care and Dementia. 2017. (freely accessible 974kb pdf)
This discussion paper provides guidance for health professionals on palliative and end-of-life care for people with dementia and those who support them.
Phillips JL, West PA, Davidson PM, Agar M. Does case conferencing for people with advanced dementia living in nursing homes improve care outcomes: evidence from an integrative review? Int J Nurs Stud. 2013 Aug;50(8):1122-35.
This integrative review aimed to appraise the evidence for case conferencing as an intervention to improve palliative care outcomes for older people living with advanced dementia in nursing homes. Results found case conferencing provides opportunities to improve care palliative care outcomes for older people with dementia by engaging family and all relevant internal and external health providers in prospective care planning. More evidence is needed to determine the efficacy and cost-effectiveness of case conferencing as a strategy for improving care outcomes for older people living with advanced dementia in nursing homes. The evidence generated by this integrative review will be of interest to policy makers, aged care organisations and clinicians alike, especially as services endeavour to meet the increasingly complex care needs of older people admitted to nursing homes with advanced dementia, and the needs of their families.
Walsh SC, Murphy E, Devane D, Sampson EL, Connolly S, Carney P, O'Shea E. Palliative care interventions in advanced dementia. Cochrane Database Syst Rev. 2021 Sep 28;9(9):CD011513. doi: 10.1002/14651858.CD011513.pub3. [Update].
This systematic review discusses the need for better evidence in palliative care in advanced dementia.
The peer-reviewed paper presenting the development and evaluation of the discussion tool is also available:
Clinical practice guidelines for people with dementia Dementia Australia (freely available website)
This set of guidelines includes Clinical Practice Guidelines and a Consumer Companion Guide
Professional resources. Dementia Australia Current (freely accessible website)
Dementia Australia offers a number of resources which may assist professionals in understanding the many aspects of living with dementia. Resources are available for cultural diversity, Aboriginal and Torres Islander peoples, LGBTI individuals and information about dementia in many different languages.
Clinical evidence - Advanced Dementia. CareSearch Current (freely accessible website)
Issues for palliative care of patients with dementia are provided including palliative care challenges, caregivers and care settings, prognosis and advance care planning and symptom management. A range of one-click PubMed searches for dementia and associated topics within a palliative care context are available.
Ruthirakuhan M, Lanctôt KL, Vieira D, Herrmann N. Natural and Synthetic Cannabinoids for Agitation and Aggression in Alzheimer's Disease: A Meta-Analysis. J Clin Psychiatry. 2019 Jan 29;80(2). pii: 18r12617. doi: 10.4088/JCP.18r12617
As many countries review therapeutic access to cannabinoids such as tetrahydrocannabinol (THC) and synthetic cannabinoids, this review examined the evidence for application in the treatment of agitation and aggression in Alzheimer’s disease. The meta-analysis does not provide evidence either for or against the efficacy of cannabinoids in the context examined. However, it supports the need for new research that separates THC and synthetic forms and highlights the potential importance of condition severity on outcomes. The significant association of use with increased sedation warrants caution and close monitoring of safety in this vulnerable population.
Page last updated 09 February 2022